Hair Dye Use Implicated in Unexplained Fainting of 61‑Year‑Old Indian Man

A 61‑year‑old Indian male was taken to the emergency department after suffering two short fainting spells, each preceded by nausea and lasting only a few minutes. The initial episode lasted approximately three minutes, and a second bout of roughly two minutes occurred soon after, leading doctors to assess him promptly.

Early investigations targeted common causes such as cardiac arrhythmia, neurological incidents, and metabolic disturbances. Electrocardiograms, laboratory panels, and imaging studies showed no significant findings, leaving the cause of the syncope unidentified. With the work‑up at an impasse, the medical team expanded questioning to include recent lifestyle modifications and possible exposures.

In a thorough interview, the man revealed that he had used an over‑the‑counter hair dye at home the day prior to the episodes. The product listed para‑phenylenediamine (PPD) among its ingredients, an aromatic amine that can elicit strong allergic reactions in vulnerable people. Published studies note that PPD may cause systemic vasodilation or anaphylactic reactions, both capable of causing abrupt blood‑pressure falls and consequent syncope.

While systemic reactions to hair dyes are uncommon, this incident highlights the difficulty they can create in diagnosis. When routine tests fail to explain symptoms, an exhaustive exposure history—covering cosmetics, household chemicals, and OTC items—may uncover obscure triggers. Here, the timing of the dye use relative to the fainting events, together with the lack of alternative pathology, identified the hair dye as the most likely cause.

He was treated with supportive measures, such as IV fluids and continuous monitoring, and made a full recovery without additional problems. Physicians advised him to stop using the implicated product and to consider alternatives with safer ingredients. Follow‑up guidance stressed the importance of recognizing early signs—nausea, dizziness, or skin irritation—following cosmetic use.

Public health authorities point out that, despite the popularity of hair dyes, regulators are still assessing the safety of components such as PPD. Users are urged to conduct patch tests, examine ingredient labels, and seek medical advice if they have a known allergy history. For doctors, this case acts as a reminder to factor in non‑medical exposures when confronted with unexplained fainting, guaranteeing that therapy targets the underlying trigger instead of merely alleviating symptoms.